T1	intervention 0 35	Perioperative intravenous lidocaine
T2	condition 162 197	persistent postsurgical pain (PPSP)
T3	total-participants 399 409	Thirty-six
T12	outcome 1133 1167	pain intensity-visual analog scale
T13	outcome 1227 1249	Secondary hyperalgesia
T14	outcome 1452 1473	analgesic consumption
T9	iv-bin-abs 947 950	Two
T15	iv-bin-percent 952 957	11.8%
T10	cv-bin-abs 995 996	9
T16	cv-bin-percent 998 1003	47.4%
T21	condition 50 78	incidence of persistent pain
T17	iv-cont-mean 1190 1194	14.6
T22	iv-cont-sd 1197 1201	22.5
T18	cv-cont-mean 1206 1209	2.6
T23	cv-cont-sd 1212 1215	7.5
T19	iv-cont-mean 1376 1379	0.2
T24	iv-cont-sd 1382 1385	0.8
T20	cv-cont-mean 1390 1393	3.2
T25	cv-cont-sd 1396 1402	4.5 cm
T26	outcome 1251 1299	area of hyperalgesia/length of surgical incision
T27	outcome 1563 1593	incidence and severity of PPSP
T6	outcome 1044 1070	PPSP at 3 months follow-up
T4	control 673 695	saline (control group)
